AVANOS MEDICAL, INC. (AVNS) Return on equity 2016–2025
AVANOS MEDICAL, INC. (AVNS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-9.4%FY2025 · since FY2016: 3.6% → -9.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -9.4% | +38.0 pp |
| FY2024 | -47.3% | -42.3 pp |
| FY2023 | -5.0% | -8.9 pp |
| FY2022 | 3.9% | +3.4 pp |
| FY2021 | 0.5% | +2.8 pp |
| FY2020 | -2.3% | +1.3 pp |
| FY2019 | -3.6% | -8.0 pp |
| FY2018 | 4.4% | -2.1 pp |
| FY2017 | 6.5% | +2.9 pp |
| FY2016 | 3.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice